Titre : | Comorbidity of substance misuse and mental illness in community mental health and substance misuse services (2003) |
Auteurs : | T. WEAVER ; P. MADDEN ; V. CHARLES ; G. STIMSON ; A. RENTON ; P. TYRER ; T. BARNES ; C. BENCH ; MIDDLETON H. ; N. WRIGHT ; S. PATERSON ; W. SHANAHAN ; N. SEIVEWRIGHT ; C. FORD ; COMORBIDITY OF SUBSTANCE MISUSE AND MENTAL ILLNESS COLLABORATIVE STUDY TEAM |
Type de document : | Article : Périodique |
Dans : | British Journal of Psychiatry (Vol.183, n°4, October 2003) |
Article en page(s) : | 304-313 |
Langues: | Anglais |
Discipline : | PSY (Psychopathologie / Psychopathology) |
Mots-clés : |
Thésaurus mots-clés TROUBLE BIPOLAIRE ; PRODUIT ILLICITE ; COMORBIDITE ; ENQUETE ; MEDICAMENTS ; ALCOOL ; ANXIETE ; DEPRESSION ; PSYCHOSE ; ETUDE TRANSVERSALE ; STRUCTURE DE PROXIMITEThésaurus géographique ROYAUME-UNI |
Résumé : |
BACKGROUND: Improved management of mental illness and substance misuse comorbidity is a National Health Service priority, but little is known about its prevalence and current management.
AIMS: To measure the prevalence of comorbidity among patients of community mental health teams (CMHTs) and substance misuse services, and to assess the potential for joint management. METHOD: Cross-sectional prevalence survey in four urban UK centres. RESULTS: Of CMHT patients, 44% (95% CI 38.1-49.9) reported past-year problem drug use and/or harmful alcohol use; 75% (95% CI 68.2-80.2) of drug service and 85% of alcohol service patients (95% CI 74.2-93.1) had a past-year psychiatric disorder. Most comorbidity patients appear ineligible for cross-referral between services. Large proportions are not identified by services and receive no specialist intervention. CONCLUSIONS: Comorbidity is highly prevalent in CMHT, drug and alcohol treatment populations, but may be difficult to manage by cross-referral psychiatric and substance misuse services as currently configured and resourced. |
Domaine : | Plusieurs produits / Several products |
Refs biblio. : | 34 |
Affiliation : | Dpt of Social Science and Medicine, Imperial College London, Charing Cross Campus, The Reynolds Building, St Dunstan's Rd, London, UK |
Numéro Toxibase : | 1300804 |
Centre Emetteur : | 13 OFDT |
Cote : | A01537 |
Accueil